Munich — EQT Ventures leads USD 15 million seed round for start up Origin.Bio. In addi­tion to EQT Ventures, other backers include Bluey­ard and Inven­tures. DLA Piper advi­sed EQT Ventures on its invest­ment in the Munich-based start-up Origin.Bio in this seed round.

Since its foun­ding in 2021, Origin.Bio, a synthe­tic biology company, has been connec­ting bioen­gi­neers with nature. It produ­ces synthe­tic micro­or­ga­nisms that can produce many of the same subs­tances that tradi­tio­nal chemi­cal indus­try proces­ses do today, but with signi­fi­cantly lower energy use and waste gene­ra­tion and avoi­ding petro­leum chemi­cals. The company provi­des the link between R&D‑focused insti­tu­ti­ons and manu­fac­tu­r­ers and increased climate-focu­­sed innovation.

EQT Ventures is the venture capi­tal fund of the Swedish private equity fund EQT Part­ners. EQT Ventures invests in fast-growing, inno­va­tive and tech­­no­­logy-driven compa­nies in all sectors world­wide, with a focus on Europe and the US.

Advi­sors to EQT Ventures: DLA Piper
The DLA Piper team, led by Part­ner Andreas Füch­sel (Private Equity/M&A), contin­ued to include Part­ner Semin O (Liti­ga­tion & Regu­la­tory), Coun­sel Kaja Herr­mann (Labor Law), Senior Asso­ciate Phil­ipp Groll (Private Equity/M&A) and Asso­cia­tes Alex­an­der Rösch (Liti­ga­tion & Regu­la­tory), Johan­nes Klug (Labor Law, all Frank­furt) and Jessica Herr­mann (Corpo­rate, Munich).

About DLA Piper
DLA Piper is one of the world’s leading commer­cial law firms, with offices in more than 40 count­ries in Africa, Asia, Austra­lia, Europe, the Middle East, and North and South America. In Germany, DLA Piper is repre­sen­ted by more than 240 lawy­ers at its offices in Frank­furt, Hamburg, Colo­gne and Munich. In certain juris­dic­tions, this infor­ma­tion may be conside­red attor­ney adver­ti­sing. www.dlapiper.com